Expression of TRAIL and TRAIL receptors in normal and malignant tissues (Q56876470)

1

0 references

Helen TURLEY

2

0 references

Fiona C KIMBERLEY

3

0 references

Xue Song LIU

4

0 references

Juthathip MONGKOLSAPAYA

5

0 references

Paul CH'EN

6

0 references

Xiao Ning XU

7

0 references

Boquan JIN

8

0 references

Francesco PEZZELLA

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

9

0 references

publication date

June 2005

0 references

published in

Cell Research

0 references

volume

15

0 references

issue

6

0 references

page(s)

430-438

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

A novel receptor for Apo2L/TRAIL contains a truncated death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

TRAIL death pathway expression and induction in thyroid follicular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Apoptosis and autoimmune thyroid disease: following a TRAIL to thyroid destruction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Expression of TRAIL and its receptors in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L gene therapy for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Lethal effect of the anti-Fas antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Normal thymocyte negative selection in TRAIL-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

7 January 2021

Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

7 January 2021

Critical roles of TRAIL in hepatic cell death and hepatic inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

7 January 2021

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

7 January 2021

Involvement of TRAIL and its receptors in viral hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

7 January 2021

Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

7 January 2021

Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

7 January 2021

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290311

7 January 2021